ICU Medical (ICUI) CIO Ben Sousa sells 2,250 shares of common stock

Rhea-AI Filing Summary

ICU Medical Inc/DE Chief Information Officer Ben Sousa reported a sale of 2,250 shares of common stock on 2026-08-12 in an open market or private transaction. The shares were sold at $178.3152 per share, leaving him with 3,076 shares of directly held common stock.

Insider Trade Summary

Net Seller: 2,250 shares

Net Sell 1 txn

Insider Sousa Ben

Role Chief Information Officer

Sold 2,250 shs ($401K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1	2,250	$178.3152	$401K

Holdings After Transaction: Common Stock — 3,076 shares (Direct)

Footnotes (1)

1. F1. All shares sold were sold at the exact price disclosed.

Key Figures

Shares sold: 2,250 shares Sale price per share: $178.3152 Shares held after transaction: 3,076 shares

3 metrics

Shares sold 2,250 shares Common stock sale reported on 2026-08-12

Sale price per share $178.3152 Per-share price for all shares sold in the transaction

Shares held after transaction 3,076 shares Directly held ICU Medical common stock following the sale

Key Terms

Form 4, Chief Information Officer, open market or private transaction

3 terms

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Chief Information Officer financial

""officer_title": "Chief Information Officer""

A chief information officer (CIO) is a senior executive responsible for managing a company's technology and information systems. They ensure that technology supports the organization’s goals, much like a conductor coordinating an orchestra to create harmonious music. Investors care about CIOs because their decisions and strategies can influence a company's efficiency, security, and ability to adapt to new digital opportunities.

open market or private transaction financial

""transaction_code_description": "Sale in open market or private transaction""

FAQ

What insider transaction did ICU Medical (ICUI) report for Ben Sousa?

ICU Medical reported that Chief Information Officer Ben Sousa sold 2,250 shares of common stock on 2026-08-12 in an open market or private transaction at a stated per-share price.

At what price were the ICU Medical (ICUI) shares sold by Ben Sousa?

Ben Sousa’s reported sale was executed at $178.3152 per share. A related footnote states that all shares sold in this transaction were sold at exactly the disclosed per-share price.

How many ICU Medical (ICUI) shares does Ben Sousa hold after the sale?

Following the reported transaction, Ben Sousa directly holds 3,076 shares of ICU Medical common stock. This post-transaction holding reflects his position after selling 2,250 shares on 2026-08-12.

What role does Ben Sousa hold at ICU Medical (ICUI)?

Ben Sousa is reported as Chief Information Officer of ICU Medical Inc/DE. The Form 4 identifies him as an officer, not a director and not a 10% beneficial owner of the company’s common stock.

Was the ICU Medical (ICUI) insider sale under a Rule 10b5-1 trading plan?

The filing’s Rule 10b5-1 affirmation box is not checked, and no footnote describes a trading plan. Based on this disclosure, the reported sale is not identified as being made under a Rule 10b5-1 plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/12/2026 - 04:33 PM Accepted by SEC EDGAR 08/12/2026 - 04:33 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sousa Ben

(Last) (First) (Middle)

951 CALLE AMANECER

(Street)

SAN CLEMENTE CALIFORNIA 92673

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ICU MEDICAL INC/DE [ ICUI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Information Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		S		2,250	D	$178.3152(1)	3,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. All shares sold were sold at the exact price disclosed.

	By: Paula Darbyshire, Attorney-in-Fact For: Benjamin Sousa	08/12/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)